Anastasia Shapiro

Title: Innovations by Anastasia Shapiro

Introduction

Anastasia Shapiro is a prominent inventor based in Rehovot, Israel. She has made significant contributions to the field of biotechnology, particularly in the area of RNA silencing and cancer treatment. With a total of 2 patents, her work is paving the way for innovative therapeutic approaches.

Latest Patents

Anastasia's latest patents include groundbreaking research on p21 mRNA target areas for silencing. This patent discloses compositions of matter comprising RNA silencing molecules capable of mediating cleavage of p21 mRNA. The methods outlined in this patent aim to eradicate senescent cells or cancer cells, as well as treat senescence-associated diseases or disorders, cancer, and fibrotic diseases and disorders. Another significant patent focuses on p21 mRNA targeting DNAzymes. This composition of matter comprises a DNAzyme molecule capable of mediating cleavage of p21 mRNA, with a nucleic acid sequence at least 80% identical to specified sequences. Similar to her first patent, this invention also addresses methods for eradicating senescent cells or cancer cells and treating related diseases.

Career Highlights

Anastasia Shapiro is currently associated with 1E Therapeutics Ltd., where she continues to advance her research and innovations. Her work is characterized by a strong focus on developing effective treatments for serious health conditions.

Collaborations

Anastasia collaborates with notable colleagues, including Noam Pilpel and Yossi Ovadya. Their combined expertise enhances the potential impact of their research in the field.

Conclusion

Anastasia Shapiro's contributions to biotechnology through her innovative patents are significant. Her work not only addresses critical health challenges but also showcases the potential of RNA silencing technologies.